R 534 (Divalproex Sodium Extended-Release 500 mg)

Pill with imprint R 534 is Gray, Elliptical/Oval and has been identified as Divalproex Sodium Extended-Release 500 mg. It is supplied by Dr. Reddy's Laboratories Ltd.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R 534

Divalproex sodium extended-release 500 mg R 534 Front

Divalproex sodium extended-release 500 mg R 534 Back

Divalproex Sodium Extended-Release

Imprint: R 534
Strength: 500 mg
Color: Gray
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule: Not a controlled drug
Labeler / Supplier: Dr. Reddy's Laboratories Ltd.
Inactive Ingredients: hypromelloses, hydroxyethyl cellulose (2000 mpa.s at 1%), lactose monohydrate, microcrystalline cellulose, silicon dioxide, hydroxypropyl cellulose, titanium dioxide, ferrosoferric oxide, ferric oxide yellow
Note: Inactive ingredients may vary.